Phase II study of paclitaxel (BMS-181339) intravenously infused over 3 hours for advanced or metastatic breast cancer in Japan

• ITOH Y.

収録刊行物

• Invest. New Drug

  Invest. New Drug 16 183-190, 1998

詳細情報

• CRID: 1570854174674689152
• NII論文ID: 10008061007
• データソース種別:
  • CiNii Articles